Can JAK Inhibitors Save Lives From COVID-19? Pfizer Might Let RECOVERY Answer The Question

Promising Signs From Phase II Study

 
• By Andrew McConaghie
  
Sao Paulo Street
The STOP-COVID study of tofacitinib was conducted in Sao Paulo, Brazil. • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip